Lead Real Estate Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell

16

LRE
Lead Real Estate

Last Price:

1.32

Seasonality Move:

--

Sell

19

APLS
Apellis Pharmaceuticals

Last Price:

32.49

Seasonality Move:

18.8%

Sell

16

Lead Real Estate (LRE) is a Sell

Is Lead Real Estate a Buy, Sell or Hold?

The current Lead Real Estate [LRE] share price is $1.31. The Score for LRE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
LRE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

19

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

LRE Stock Price Chart

What is Lead Real Estate's stock price today?

The Lead Real Estate share price today is $1.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRE is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

LRE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.12	Sell
Relative Strength Index (14 RSI):	37.42	Sell
Chaikin Money Flow:	-4328	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.37 - 1.63)	Sell
Bollinger Bands (100):	(1.2 - 4.42)	Sell

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.84	Sell
Relative Strength Index (14 RSI):	33.6	Sell
Chaikin Money Flow:	-1084788	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(36.37 - 40.01)	Sell
Bollinger Bands (100):	(36.55 - 42.35)	Sell

LRE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.37	Sell
20-day SMA:	1.45	Sell
50-day SMA:	1.66	Sell
200-day SMA:	3.83	Sell
8-day EMA:	1.38	Sell
20-day EMA:	1.46	Sell
50-day EMA:	1.84	Sell
200-day EMA:	3.6	Sell

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	36.19	Sell
20-day SMA:	38.04	Sell
50-day SMA:	37.88	Sell
200-day SMA:	50	Sell
8-day EMA:	35.96	Sell
20-day EMA:	37.21	Sell
50-day EMA:	38.25	Sell
200-day EMA:	45.7	Sell

Lead Real Estate Earnings Growth & LRE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Lead Real Estate Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):